Waksman Foundation News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Regulus Announces Addition to Board of Directors News provided by Share this article LA JOLLA, Calif., Jan. 27, 2021 /PRNewswire/  Regulus Therapeutics Inc. (Nasdaq: RGLS), a biopharmaceutical company focused on the discovery and development of innovative medicines targeting microRNAs, today announced Alice S. Huang, Ph.D. has been appointed to the Company s board of directors. Concurrently with her appointment to the Board, Dr. Huang was appointed to serve on the Compensation Committee. We are pleased to add Dr. Huang to the Regulus board.  We believe her extensive scientific background will be of benefit to helping direct the Company s drug discovery and development programs, said Stelios Papadopoulos, Ph.D., Chairman of the Board of Directors of Regulus. 

United statesUniversity of massachusettsStelios papadopoulosAlices huangJohns hopkins universityNational foundation for infectious diseasesNational cancer instituteHealth effects instituteCompensation committeeAmerican association for the advancement of scienceAmerican academy of microbiologyFood drug administrationUs army medical research developmentSchlesinger library at radcliffe instituteRegulus therapeutics incAmerican association of women